| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 3832-3841, Copyright © 1996 by Endocrine Society
ARTICLES |
AM Valverde, T Teruel, M Lorenzo and M Benito
Departamento de Bioquimica y Biologia Molecular II, Facultad de Farmacia, Universidad Complutense, Madrid, Spain.
In the present study we have examined the signaling cascades involved in insulin-like growth factor I (IGF-I)-induced mitogenesis in fetal rat brown adipocyte primary cultures, a model that constitutively expresses a high number of IGF-I receptors, where IGF-I is a complete mitogen at physiological concentrations. IGF-I rapidly stimulated beta- chain IGF-I receptor autophosphorylation, which peaked at a physiological/mitogenic concentration (1.4 nM) and also stimulated tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1). Tyrosine-phosphorylated IRS-1 bound and subsequently activated phosphatidylinositol 3-kinase by 3.5-fold, whereas the tyrosine- phosphorylated IGF-I receptor was not directly associated with the p85 subunit of the phosphatidylinositol 3-kinase. Moreover, mitogenic concentrations of IGF-I enhanced glucose transport by 2.5-fold. In addition, tyrosine phosphorylation of the 46- and 52-kDa SHC proteins was high in the basal state and doubled after IGF-I treatment, whereas IGF-I enhanced by 4-fold tyrosine phosphorylation of the 66-kDa SHC band. Furthermore, a 2-fold increase in the Ras. GTP active form was induced upon IGF-I stimulation. Downstream from Ras, IGF-I increased both Raf kinase and protein kinase C (PKC) zeta activities by 3.5-fold. (Bu)2cAMP, an inhibitor of IGF-I-induced mitogenesis in fetal brown adipocyte primary cultures, did not block the very early steps of the IGF-I-induced mitogenic cascade, such as IGF-I receptor autophosphorylation, IRS-1 or SHC tyrosine phosphorylation, and Ras activation to its GTP active form. However, (Bu)2cAMP disrupted IGF-I- Raf and IGF-I-PKC zeta signaling pathways by preventing IGF-I-induced Raf-1 kinase and PKC zeta enzymatic activities, respectively. Our results show the first characterization in situ of an IGF-I mitogenic signaling cascade that downstream Ras diverges to the nucleus through two different serine/threonine kinases (Raf-1 kinase and PKC zeta) in mammalian fetal primary cells under physiological conditions. Both kinases represent a point of regulation primarily described for IGF-I- induced, cAMP-inhibited mitogenic pathways.
This article has been cited by other articles:
![]() |
R. Mustafi, S. Cerda, A. Chumsangsri, A. Fichera, and M. Bissonnette Protein Kinase-{zeta} Inhibits Collagen I-Dependent and Anchorage-Independent Growth and Enhances Apoptosis of Human Caco-2 Cells Mol. Cancer Res., September 1, 2006; 4(9): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hurbin, J.-L. Coll, L. Dubrez-Daloz, B. Mari, P. Auberger, C. Brambilla, and M.-C. Favrot Cooperation of Amphiregulin and Insulin-like Growth Factor-1 Inhibits Bax- and Bad-mediated Apoptosis via a Protein Kinase C-dependent Pathway in Non-small Cell Lung Cancer Cells J. Biol. Chem., May 20, 2005; 280(20): 19757 - 19767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arcaroli, K.-Y. Yang, H.-K. Yum, J. Kupfner, T. M. Pitts, J. S. Park, D. Strassheim, and E. Abraham Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia J. Leukoc. Biol., September 1, 2002; 72(3): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mur, A. M. Valverde, C. R. Kahn, and M. Benito Increased Insulin Sensitivity in IGF-I Receptor-Deficient Brown Adipocytes Diabetes, March 1, 2002; 51(3): 743 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Radke, K. Johnson, R. Guo, A. Davidson, and L. Ambrosio Drosophila-Raf Acts to Elaborate Dorsoventral Pattern in the Ectoderm of Developing Embryos Genetics, November 1, 2001; 159(3): 1031 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Valverde, C. Mur, S. Pons, A. M. Alvarez, M. F. White, C. R. Kahn, and M. Benito Association of Insulin Receptor Substrate 1 (IRS-1) Y895 with Grb-2 Mediates the Insulin Signaling Involved in IRS-1-Deficient Brown Adipocyte Mitogenesis Mol. Cell. Biol., April 1, 2001; 21(7): 2269 - 2280. [Abstract] [Full Text] |
||||
![]() |
C. M. Boney, P. A. Gruppuso, R. A. Faris, and A. R. Frackelton Jr. The Critical Role of Shc in Insulin-Like Growth Factor-I-Mediated Mitogenesis and Differentiation in 3T3-L1 Preadipocytes Mol. Endocrinol., June 1, 2000; 14(6): 805 - 813. [Abstract] [Full Text] |
||||
![]() |
P. Navarro, A. M. Valverde, M. Benito, and M. Lorenzo Activated Ha-ras Induces Apoptosis by Association with Phosphorylated Bcl-2 in a Mitogen-activated Protein Kinase-independent Manner J. Biol. Chem., July 2, 1999; 274(27): 18857 - 18863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Valverde, M. Lorenzo, S. Pons, M. F. White, and M. Benito Insulin Receptor Substrate (IRS) Proteins IRS-1 and IRS-2 Differential Signaling in the Insulin/Insulin-Like Growth Factor-I Pathways in Fetal Brown Adipocytes Mol. Endocrinol., May 1, 1998; 12(5): 688 - 697. [Abstract] [Full Text] |
||||
![]() |
M. R. Sanders, H. Lu, F. Walker, S. Sorba, and N. Dainiak The Raf-1 Protein Mediates Insulin-Like Growth Factor-Induced Proliferation of Erythroid Progenitor Cells Stem Cells, May 1, 1998; 16(3): 200 - 207. [Abstract] [Full Text] |
||||
![]() |
A. M. Valverde, T. Teruel, P. Navarro, M. Benito, and M. Lorenzo Tumor Necrosis Factor-{alpha} Causes Insulin Receptor Substrate-2-Mediated Insulin Resistance and Inhibits Insulin-Induced Adipogenesis in Fetal Brown Adipocytes Endocrinology, March 1, 1998; 139(3): 1229 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Valverde, M. Lorenzo, P. Navarro, and M. Benito Phosphatidylinositol 3-Kinase Is a Requirement for Insulin-Like Growth Factor I-Induced Differentiation, but not for Mitogenesis, in Fetal Brown Adipocytes Mol. Endocrinol., May 1, 1997; 11(5): 595 - 607. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |